Correlation of glatiramer acetate (GA) antibodies and cytokine shifts with clinical response to GA on multiple sclerosis

被引：0
|
作者：
Valenzuela, Reuben M.
Sicsic, Camille
Brenner, Talma
Dhib-Jalbut, Suhayl
机构：
来源：
NEUROLOGY | 2007年 / 68卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A20 / A20
页数：1
相关论文
共 50 条
  • [1] Predictive Biomarkers of Clinical Response to Glatiramer Acetate (GA) Therapy in Multiple Sclerosis (MS)
    Valenzuela, Reuben Mari
    Kaufman, Michael D.
    Russo, Priscilla C.
    Picone, Mary Anne
    Halper, June
    Costello, Kathy
    Rosario, Yaritza M.
    Balashov, Konstantin
    Ito, Kouichi
    Dhib, Suhayl
    NEUROLOGY, 2009, 72 (11) : A469 - A470
  • [2] Predictive cytokine biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
    Valenzuela, R. M.
    Kaufman, M.
    Balashov, K. E.
    Ito, K.
    Buyske, S.
    Dhib-Jalbut, S.
    JOURNAL OF NEUROIMMUNOLOGY, 2016, 300 : 59 - 65
  • [3] The effect of glatiramer acetate (GA) on cognitive function in an animal model of multiple sclerosis
    Aharoni, R.
    Schottlender, N.
    Bar Lev, D. D.
    Tsoory, M.
    Sela, M.
    Arnon, R.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 495 - 495
  • [4] Modulation of IL-18 and caspase-1 expression correlates with the clinical response to glatiramer acetate (GA) in multiple sclerosis
    Valenzuela, RM
    Rus, H
    Ito, K
    Dhib-Jalbut, S
    NEUROLOGY, 2006, 66 (05) : A175 - A175
  • [5] Long Term Treatment of Multiple Sclerosis with Glatiramer Acetate: Natural History of the Subtypes of Anti-Glatiramer Acetate Antibodies and Their Correlation with Clinical Efficacy
    Brenner, Talma
    Teitelbaum, Dvora
    Sicsic, Camille
    Karussis, Dimitrios
    NEUROLOGY, 2010, 74 (09) : A423 - A423
  • [6] Glatiramer acetate (GA) is effective in neutralizing antibodies to IFNb positive (NAb plus ve) multiple sclerosis (MS) patients
    Capobianco, Marco
    Malucchi, Simona
    Sperli, Francesca
    Di Sapio, Alessia
    Oggero, Alessandra
    Valentino, Paola
    Granieri, Letizia
    Marnetto, Fabiana
    Caldano, Marzia
    Gilli, Francesca
    Sala, Arianna
    Bertolotto, Antonio
    NEUROLOGY, 2008, 70 (11) : A94 - A95
  • [7] Long-term treatment of multiple sclerosis with glatiramer acetate: Natural history of the subtypes of anti-glatiramer acetate antibodies and their correlation with clinical efficacy
    Karussis, Dimitros
    Teitelbaum, Dvora
    Sicsic, Camille
    Brenner, Talma
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 220 (1-2) : 125 - 130
  • [8] Clinical Response to Glatiramer Acetate Correlates with the Ex Vivo GA-Induced IFNγ and IL4 mRNA Response in Patients with Multiple Sclerosis
    Bertolotto, Antonio
    Navone, Nicole D.
    Valentino, Paola
    Caldano, Marzia
    Perga, Simona
    Malucchi, Simona
    Gilli, Francesca
    NEUROLOGY, 2011, 76 (09) : A333 - A333
  • [9] Glatiramer acetate for multiple sclerosis
    La Mantia, Loredana
    Munari, Luca M.
    Lovati, Roberta
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (05):
  • [10] Effects of interferon and glatiramer acetate on cytokine patterns in multiple sclerosis patients
    Ganji, Ali
    Monfared, Mohsen Ebrahimi
    Shapoori, Shima
    Nourbakhsh, Parisa
    Ghazavi, Ali
    Ghasami, Keyvan
    Mosayebi, Ghasem
    CYTOKINE, 2020, 126
12345